The protein tyrosine phosphatase-like molecule IA-2 is a new member of the transmembrane protein tyrosine phosphatase (PTP) family [1, 2] . It is distantly related to other transmembrane PTPs with 35±40 % sequence similarity in the intracellular domain. It is also closely related to another new member of the transmembrane PTP family, IA-2b, with 74 % identity in the intracellular domain [3, 4] . Human IA-2 and mouse IA-2 are, however, very closely related to each other showing 98 % identity in the intracellular domain and 92 % identity in the extracellular domain [5] . Although IA-2 is a member of the PTP family based on sequence analysis, it lacks enzymatic activity with conventional PTP substrates [2] .
as predictive markers for identifying people at high risk of becoming diabetic [10] . The function of IA-2 is still not known. For a better understanding of this molecule, with the long-term goal of knocking out the gene, knowledge of its genomic structure is essential. We report the complete genomic structure of mouse IA-2 and compare it with the recently reported genomic structure of human IA-2 [13] (GenBank accession numbers L18 983 and AF042 285).
Materials and methods
Screening of genomic libraries. A 129SVJ mouse genomic library, constructed in lambda FIX II vector (Stratagene, La Jolla, Calif., USA), was screened by enzyme-derived chemillkuminescence non-radioactive plaque hybridization and detection method (Amersham, Arlington Heights, Ill., USA). Positive clones were confirmed by restriction enzyme mapping and Southern blot hybridization with a mouse IA-2 cDNA probe.
Restriction enzyme mapping. Phage DNA was prepared from culture lysates with a Wizard Lamda DNA preparation kit (Promega, Madison, Wis., USA). We selected and mapped seven overlapping clones by the restriction enzymes Apa I, BamH I, EcoR I, Hind III, Sac I, Xho I and Kpn I with a FLASH non-radioactive gel mapping kit (Stratagene, La Jolla, Calif., USA). The position of the restriction enzyme sites was determined by mapping from both ends and confirmed by analysis of the band pattern from complete digestion.
Intron-exon boundaries. Cloned genomic DNA lambda phage was digested by different restriction enzymes, separated on agarose gels and Southern blotted with cDNA probes. Exoncontaining fragments were subcloned into a pBluescript II vector (Stratagene). Nested deletions of cloned inserts were prepared by exonuclease digestion, the religated plasmids were amplified and used as templates for sequencing. Each exon-intron junction was determined by sequence analysis and compared with mouse IA-2 cDNA (GenBank accession number Ul1872). The size of introns was estimated by the sequence data or calculated by the distance from restriction enzyme sites.
Mapping 3' and 5' ends of mRNAs. The 3' cDNA end and 5' transcription start sites were determined with RNA prepared from mouse b-TC-1 cells. Total RNA was extracted from these cells [14] and then subjected to reverse transcription with (dT) 17-adaptor primer (3' mapping) or mIA-2 anti-sense primer (gttccatctcctgggagatcacatgct) (5' mapping). The procedure for rapid amplification of cDNA ends (RACE) was done as described previously [15] and repeated twice using appropriate nested primers. The final products were gel purified and subcloned into a pCRscript vector (Stratagene). Plasmid DNA from clones picked at random was subjected to DNA sequencing and aligned with the genomic sequence.
DNA sequencing. All subcloned genomic fragments and cloned RACE products were sequenced by an automated DNA sequencer managed by the core facilities in the National Institute of Dental and Craniofacial Research.
Results
To determine its genomic structure, mouse IA-2 cDNA probes were used to screen a 129SVJ mouse genomic library. Seven overlapping clones were se-" lected and mapped by the restriction enzymes. The genomic fragments corresponding to the whole IA-2 cDNA were assembled and the restriction map is shown in Figure 1 . The intron-exon junctions of the IA-2 gene were determined by directly sequencing nested deletion clones of subcloned genomic fragments. Table 1 shows the size of each exon and intron, the sequence at each exon-intron junction and the position of the amino acid where the intron is located. The mouse IA-2 gene consists of 23 exons. The relative position of each exon is indicated (Fig. 1) . The size of the exons range from the shortest (exon 8) with 38 nucleotides to the longest (exon 23) with 578 nucleotides in the 3' UTR region. A long exon in the 3' UTR also is found in other members of the PTP family
[16±18]. The entire 5'-untranslated region and the first 42 amino acids are encoded by exon 1. The extracellular region is encoded by exons 1 to 13, the transmembrane region by exon 13 and the intracellular region by exons 13 to 23. All of the splice acceptor and donor sequences agree with the GT/AG rule [19] and analysis of the intron sequences showed a microsatellite sequence with 20 TG repeats in intron 3 (data not shown).
The 3' cDNA end and 5' transcription start sites were determined by rapid amplification of cDNA ends (RACE). Based on sequence analysis of 11 clones, the most likely transcription start site is located at position ±26 (Fig. 2) . Comparison of both the 3' and 5' RACE data with the known cDNA sequence of IA-2 indicates that there are no introns in either the 5' or 3' UTR regions. The start of the poly A tail of mIA-2 cDNA was found 25 nucleotides downstream of the last polyA signal (AATAAA) as indicated at the bottom of Table 1 .
By automated DNA sequencing, 1631 bp of the 5'-upstream region from the transcription start site were determined (Fig. 2) . To test for promoter activity, this region was fused to the luciferase report gene (pGL3 basic Promega). Transient transfection of PC12 and RIN cells resulted in a 10 to 15-fold increase in luciferase activity. The region around the major transcription start site, similar to human IA-2 and other , was found to be highly ªGCº rich and contained multiple putative Sp1 binding sites. Several Sp1 sites also were found in the 5' end of the first intron (Fig. 2) . The 5'-upstream region of both the human and mouse IA-2 gene lack a TATA box and show similar potential transcription binding sites.
Discussion
Comparison of the genomic structure of mouse and human IA-2 shows that both species have 23 exons and like many mammalian genes [20, 21] show very similar intron-exon junctions (Fig. 3) . The coding region of 19 of the 23 mouse and human exons possess the same number of nucleotides with the majority showing greater than 90 % identity. Similarly, 19 of the 23 mouse and human exons possess the same number of amino acids with 13 of the 19 showing greater than 96 % identity. The greatest discrepancy is found in the extracellular region where the amino acids of human and mouse exons 1 and 5±9 are only 64 % to 84 % identical. The amino acids in the exon encoding the transmembrane region (exon 13) are 87 % identical, whereas the amino acids in the exons encoding the intracellular region (exons 13 to 23) of mouse and human IA-2 are 93 % to 100 % identical. This high degree of sequence and structural identity indicates that the IA-2 gene is derived from a highly 
